Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Chronic Heart Failure

  Free Subscription


3 Am Heart J
2 Am J Cardiol
1 Cardiovasc Res
1 Circ Res
1 Clin Cardiol
24 Eur J Heart Fail
2 Heart
1 Int J Cardiol
1 J Am Coll Cardiol
4 J Card Fail
1 J Cardiol
2 J Thorac Cardiovasc Surg

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am Heart J

  1. SHAHZEB KHAN M, Kristensen SL, Vaduganathan M, Kober L, et al
    Natriuretic Peptide Plasma Concentrations and Risk of Cardiovascular Versus Non-Cardiovascular Events in Heart Failure with Reduced Ejection Fraction Insights from the PARADIGM-HF and ATMOSPHERE Trials.
    Am Heart J. 2021 Feb 20. pii: S0002-8703(21)00054.
    PubMed         Abstract available

  2. JENTZER JC, Ahmed AM, Vallabhajosyula S, Burstein B, et al
    Shock in the cardiac intensive care unit: Changes in epidemiology and prognosis over time.
    Am Heart J. 2021;232:94-104.
    PubMed         Abstract available

  3. SALAH HM, Al'Aref SJ, Khan MS, Al-Hawwas M, et al
    Effect of sodium-glucose cotransporter 2 inhibitors on cardiovascular and kidney outcomes-Systematic review and meta-analysis of randomized placebo-controlled trials.
    Am Heart J. 2020;232:10-22.
    PubMed         Abstract available

    Am J Cardiol

  4. HORIUCHI Y, Wettersten N, van Veldhuisen DJ, Mueller C, et al
    Relation of Decongestion and Time to Diuretics to Biomarker Changes and Outcomes in Acute Heart Failure.
    Am J Cardiol. 2021 Feb 19. pii: S0002-9149(21)00152.
    PubMed         Abstract available

  5. SIEBERT U, Milev S, Zou D, Litkiewicz M, et al
    Economic Evaluation of an N-terminal pro B-type Natriuretic Peptide-supported Diagnostic Strategy among Dyspneic Patients Suspected of Acute Heart Failure in the Emergency Department.
    Am J Cardiol. 2021 Feb 19. pii: S0002-9149(21)00145.
    PubMed         Abstract available

    Cardiovasc Res

  6. LUXAN G, Dimmeler S
    The vasculature: a therapeutic target in heart failure?
    Cardiovasc Res. 2021 Feb 23. pii: 6146925. doi: 10.1093.
    PubMed         Abstract available

    Circ Res

  7. MARTINS-MARQUES T, Catarino S, Goncalves A, Miranda-Silva D, et al
    EHD1 Modulates Cx43 Gap Junction Remodeling Associated With Cardiac Diseases.
    Circ Res. 2020;126:e97-e113.
    PubMed         Abstract available

    Clin Cardiol

  8. BRYAN RICHARD S, Huang B, Liu G, Yang Y, et al
    Impact of ivabradine on the cardiac function of chronic heart failure reduced ejection fraction: Meta-analysis of randomized controlled trials.
    Clin Cardiol. 2021 Feb 27. doi: 10.1002/clc.23581.
    PubMed         Abstract available

    Eur J Heart Fail

  9. GUSTAFSSON F, Lund LH, Metra M
    If it ain't broken, don't fix it (but if it is, make sure you know): aortic valve interventions during left ventricular assist device implantation.
    Eur J Heart Fail. 2020;22:1888-1890.

    Pulmonary artery pressure monitoring, a reality for Europe?
    Eur J Heart Fail. 2020;22:1905-1906.

    Beating the bushes for biomarkers.
    Eur J Heart Fail. 2020;22:2075-2077.

  12. JANKOWSKA EA, Tkaczyszyn M, Ponikowski P
    Myocardial iron content in non-ischaemic cardiomyopathy: how much is known?
    Eur J Heart Fail. 2020;22:2047-2048.

    Is cardio-oncology a rapidly growing field of precision medicine?
    Eur J Heart Fail. 2020;22:2310-2313.

  14. BHATT AS, Vaduganathan M
    Discovery and care innovation amidst a pandemic.
    Eur J Heart Fail. 2020;22:2202-2204.

  15. FERREIRA JP, Claggett BL, Liu J, Desai AS, et al
    Serum potassium and outcomes in heart failure with preserved ejection fraction: a post-hoc analysis of the PARAGON-HF trial.
    Eur J Heart Fail. 2021 Feb 20. doi: 10.1002/ejhf.2134.
    PubMed         Abstract available

  16. OKWUOSA TM, Keramida K, Filippatos G, Yancy CW, et al
    Cancer therapy and the heart; the necessity to calibrate risk.
    Eur J Heart Fail. 2020;22:1961-1965.

    Ventricular remodelling: an equal-opportunity prognosticator.
    Eur J Heart Fail. 2020;22:2269-2271.

  18. SEFEROVIC PM, Polovina M
    In search of a 'safety zone' for glycaemic control: association between glycosylated haemoglobin levels and outcomes in patients with type 2 diabetes and cardiovascular disease.
    Eur J Heart Fail. 2020;22:2035-2037.

  19. KEHLER DS, Arora RC
    Frailty and the failing heart do not travel alone.
    Eur J Heart Fail. 2020;22:2120-2122.

  20. COWIE MR
    DAPA-HF: does dapagliflozin provide 'bang for your buck' as a treatment for heart failure with reduced ejection fraction?
    Eur J Heart Fail. 2020;22:2157-2159.

  21. PARIKH PB, Tsigkas G, Kalogeropoulos AP
    Transcatheter aortic valve replacement after heart failure hospitalization: too little, too late?
    Eur J Heart Fail. 2020;22:1875-1877.

  22. ADAMO M, Metra M, Alfieri O
    Percutaneous valve repair of functional mitral regurgitation: aiming at optimal and durable results.
    Eur J Heart Fail. 2020;22:1849-1851.

  23. GRIFFIN JM, Maurer MS
    Cardiac amyloidosis in severe aortic stenosis: we can find it but what should we do?
    Eur J Heart Fail. 2020;22:1863-1865.

  24. SCHNEIDER M, Mascherbauer J
    Improvement in nutritional status - a determinant of successful transcatheter tricuspid valve repair?
    Eur J Heart Fail. 2020;22:1837-1839.

  25. BHATIA K, Jain V, Gupta K, Bansal A, et al
    Prevention of Heart Failure Events with SGLT-2 Inhibitors Across a Spectrum of Cardio-Renal-Metabolic Risk.
    Eur J Heart Fail. 2021 Feb 20. doi: 10.1002/ejhf.2135.
    PubMed         Abstract available

  26. TROMP J, Ponikowski P, Salsali A, Angermann CE, et al
    SGLT2 inhibition in patients hospitalized for acute decompensated heart failure: rationale for and design of the EMPULSE trial.
    Eur J Heart Fail. 2021 Feb 20. doi: 10.1002/ejhf.2137.
    PubMed         Abstract available

  27. SLIWA K, van der Meer P, Petrie MC, Frogoudaki A, et al
    Risk stratification and management of women with cardiomyopathy/heart failure planning pregnancy or presenting during/after pregnancy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on Peripar
    Eur J Heart Fail. 2021 Feb 20. doi: 10.1002/ejhf.2133.
    PubMed         Abstract available

    Biochemical or clinical heart failure, not so simple.
    Eur J Heart Fail. 2021 Feb 26. doi: 10.1002/ejhf.2128.

  29. SEFEROVIC PM, Vardas P, Jankowska EA, Maggioni AP, et al
    The Heart Failure Association Atlas: Heart Failure Epidemiology and Management Statistics 2019.
    Eur J Heart Fail. 2021 Feb 26. doi: 10.1002/ejhf.2143.
    PubMed         Abstract available

  30. VERBRUGGE FH, Reddy YNV, Sorimachi H, Omote K, et al
    Diagnostic Scores Predict Morbidity and Mortality in Patients Hospitalised for Heart Failure with Preserved Ejection Fraction.
    Eur J Heart Fail. 2021 Feb 26. doi: 10.1002/ejhf.2142.
    PubMed         Abstract available

  31. TURGEON RD, Barry AR, Hawkins NM, Ellis UM, et al
    Pharmacotherapy for Heart Failure with Reduced Ejection Fraction and Health-Related Quality of Life: Systematic Review and Meta-Analysis.
    Eur J Heart Fail. 2021 Feb 25. doi: 10.1002/ejhf.2141.
    PubMed         Abstract available

  32. LANG NN, Ahmad FA, Cleland JG, O'Connor CM, et al
    Hemodynamic Effects of the Nitroxyl Donor Cimlanod (BMS-986231) in Chronic Heart Failure: A Randomized Trial.
    Eur J Heart Fail. 2021 Feb 23. doi: 10.1002/ejhf.2138.
    PubMed         Abstract available


    Heart failure in adults with congenital heart disease: a call for action.
    Heart. 2021 Feb 23. pii: heartjnl-2020-318757. doi: 10.1136/heartjnl-2020-318757

  34. JOSHI SS, Singh T, Newby DE, Singh J, et al
    Sodium-glucose co-transporter 2 inhibitor therapy: mechanisms of action in heart failure.
    Heart. 2021 Feb 26. pii: heartjnl-2020-318060. doi: 10.1136/heartjnl-2020-318060
    PubMed         Abstract available

    Int J Cardiol

  35. ELBADAWI A, Dang A, Elgendy IY, Thakker R, et al
    Age-specific trends and outcomes of hospitalizations with acute heart failure in the United States.
    Int J Cardiol. 2021 Feb 17. pii: S0167-5273(21)00284.
    PubMed         Abstract available

    J Am Coll Cardiol

  36. MACK MJ, Lindenfeld J, Abraham WT, Kar S, et al
    3-Year Outcomes of Transcatheter Mitral Valve Repair in Patients With Heart Failure.
    J Am Coll Cardiol. 2021;77:1029-1040.
    PubMed         Abstract available

    J Card Fail

  37. MENTZ RJ, Lala A
    Diversity, Equity and Inclusion at the Journal of Cardiac Failure.
    J Card Fail. 2021;27:263-264.

  38. KHAN SS, Huffman MD, Harrington K, Baldridge AS, et al
    Association of baseline diuretic use with cardiovascular outcomes in patients with heart failure with preserved ejection fraction: A secondary analysis from TOPCAT.
    J Card Fail. 2021 Feb 23. pii: S1071-9164(21)00082.

  39. BAMAN JR, Patil KD, Medhekar AN, Wilcox JE, et al
    Primary Prevention ICD Therapy in Heart Failure with Recovered Ejection Fraction.
    J Card Fail. 2021 Feb 23. pii: S1071-9164(21)00078.
    PubMed         Abstract available

  40. FENDLER TJ, Allen LA, Matlock DD
    Did You Forget to Assess Cognition in Your Patient With Heart Failure, and Does It Matter?
    J Card Fail. 2021;27:295-296.

    J Cardiol

  41. MAEMURA K, Ikeda Y, Oki T, Yazaki M, et al
    Clinical significance of ischemia-like electrocardiographic finding during heart failure treatment on left ventricular recovery in patients with non-ischemic dilated cardiomyopathy.
    J Cardiol. 2021 Feb 19. pii: S0914-5087(21)00037.
    PubMed         Abstract available

    J Thorac Cardiovasc Surg

    Commentary: From the trenches: Lessons on caring for patients with heart failure during coronavirus disease 2019 (COVID-19).
    J Thorac Cardiovasc Surg. 2020 Sep 4. pii: S0022-5223(20)32567.

  43. DEO SV, Sundaram V, Sahadevan J, Selvaganesan P, et al
    Outcomes of coronary artery bypass grafting in patients with heart failure with a midrange ejection fraction.
    J Thorac Cardiovasc Surg. 2021 Jan 23. pii: S0022-5223(21)00132.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Chronic Heart Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.